Nanoparticles of Anginex were used in a galectin-1-overexpressing breast cancer mouse model, showing a robust reduction in tumor growth, and similar results were obtained with Anginex analogues (6DBF7, DB16, DB21) (265). Here, LGALS1 is linked to breast carcinoma.